Biotech News
-
Sixth Wave Innovations Inc. Granted MIPS Patent for Extraction and Purification of Lithium, Mercury, and Scandium
March 29, 2022 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Zentek Announces Filing of Provisional Patent for Fire-Retardant Additive
March 28, 2022 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK; TSX-V:ZEN), a Canadian intellectual property development and commercialization…
-
Valeo Pharma Announces Listing to the Toronto Stock Exchange
The Company’s shares and warrants to start trading on March 29th, 2022 March 28, 2022 (Source) — Valeo Pharma Inc.…
-
Valeo Pharma Reports Its First Quarter 2022 Results and Highlights
Q1-22 revenues of $4.2 million, up 128% over Q1-21 Q1-22 gross margins of $1.4 million, up 266% over Q1-21 Public…
-
Zentek’s ZenGUARD(TM) Patent Application Publishes
March 24, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK) (TSX-V:ZEN), a Canadian intellectual property development and commercialization…
-
Sixth Wave Announces Closing of $2.568M Financing
March 24, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave” or the “Company”) is…
-
Hemostemix Announces Settlement Agreement
March 23, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased…
-
Valeo Pharma Secures Additional Public Reimbursement for Redesca™, Enerzair® Breezhaler® and Atectura® Breezhaler®
Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia Enerzair Breezhaler and Atectura Breezhaler…
-
Awakn Life Sciences Announces Closing of Private Placement
March 22, 2022 (Source) — Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”),…
-
Zentek To Begin Trading Common Stock on NASDAQ March 22, 2022
March 21, 2022 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK; TSX-V:ZEN; and OTC PINK:ZENYF), a Canadian intellectual property…
